NICE backs new oral MS drug, Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

NICE backs new oral MS drug, Gilenya

Postby MSUK » Fri Mar 16, 2012 3:59 am

Image


Novartis's multiple sclerosis pill Gilenya has been recommended for use on the U.K.'s publicly-funded National Health Service after a change of heart by the country's healthcare cost-effectiveness watchdog.

Friday's verdict from the National Institute for Health and Clinical Excellence, whose opinions are also watched closely in other countries, is welcome news for the Swiss company's potential blockbuster product whose safety profile has come into question recently.

NICE said it changed its mind on the medicine, also knows as fingolimod, after Novartis provided more information and analyses on the pill, allowing the British agency to compare the medicine's performance with existing injectable MS therapies.... Read More -
http://www.msrc.co.uk/index.cfm/fuseact ... geid/1309/
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service